Our Leadership
Board Members
- Masashi Miyamoto, Ph.D. (Profile)
- Representative Director, Chairman & CEO
Masashi Miyamoto, Ph.D. Profile
| Apr. 1985 | Joined Kirin Brewery Company, Limited (presently Kirin Holdings Company, Limited) |
|---|---|
| Apr. 2011 | Director, Regulatory Affairs Department, Pharmacovigilance and Quality Assurance Division, Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co., Ltd.) |
| Mar. 2012 | Executive Officer, Director, Regulatory Affairs Department, Pharmacovigilance and Quality Assurance Division, Kyowa Hakko Kirin Co., Ltd. |
| Jul. 2014 | Executive Officer, Director, Strategic Product Portfolio Department and Regulatory Affairs Department, Pharmacovigilance and Quality Assurance Division, Kyowa Hakko Kirin Co., Ltd. |
| Apr. 2015 | Executive Officer, Director, Strategic Product Portfolio Department, Kyowa Hakko Kirin Co., Ltd. |
| Mar. 2017 | Director of the Board, Managing Executive Officer, Strategic Product Portfolio Department, Kyowa Hakko Kirin Co., Ltd. |
| Apr. 2017 | Director of the Board, Managing Executive Officer, Director, Corporate Strategy & Planning Department, Kyowa Hakko Kirin Co., Ltd. |
| Mar. 2018 | Representative Director of the Board, President, Kyowa Hakko Kirin Co., Ltd. |
| Apr. 2024 | Representative Director of the Board, President & Chief Executive Officer(CEO), Kyowa Kirin Co., Ltd. |
| Mar. 2025 | Representative Director of the Board, Chairman & Chief Executive Officer(CEO), Kyowa Kirin Co., Ltd. (to present) |
- Abdul Mullick, Ph.D. (Profile)
- Representative Director, President & COO
Abdul Mullick, Ph.D. Profile
| Jan. 1999 | Global Marketing Director, Diabetes, Hoechst Marion Roussel Ltd. (presently Sanofi-Aventis Pharma AG) |
|---|---|
| Jan. 2005 | Senior Global Brand Director, Diabetes, Novartis Pharma AG |
| Dec. 2007 | EMEA Business Unit Head, Genzyme Corp. |
| Jan. 2009 | Vice President Commercial Operations – Japan, Asia-Pac, Australia & China, Genzyme Corp. |
| Jan. 2011 | Vice President, Head of Global Marketing, Rare Diseases, Genzyme Corp. |
| Jul. 2013 | Vice President & General Manager, Endocrinology and Cardiology, Rare Diseases, Genzyme USA |
| Sep. 2014 | Executive Vice President, Head of Global Marketing, Vifor Pharma Ltd |
| Mar. 2018 | Executive Vice President, Rare Disease Head, Kyowa Kirin International plc |
| Apr. 2019 | President, Kyowa Kirin International plc |
| Jan. 2023 | Managing Executive Officer, Vice Chief International Business Officer, Kyowa Kirin Co., Ltd. |
| Mar. 2023 | Managing Executive Officer, Chief International Business Officer, Kyowa Kirin Co., Ltd. |
| Apr. 2024 | Managing Executive Officer, Chief International Business Officer (CIBO), Kyowa Kirin Co., Ltd. |
| Mar. 2025 | Representative Director of the Board, President and Chief Operating Officer (COO) (to present) |
- Takeyoshi Yamashita, Ph.D. (Profile)
- Director
Executive Vice President & CMO
Takeyoshi Yamashita, Ph.D. Profile
| Apr. 1987 | Joined Kirin Brewery Company, Limited (presently Kirin Holdings Company, Limited) |
|---|---|
| Apr. 2010 | Director, Innovative Drug Discovery Laboratories, Research Division, Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co., Ltd.) |
| Apr. 2012 | Director, Research Planning Department, Research Division, Kyowa Hakko Kirin Co., Ltd. |
| Apr. 2015 | Director, Regulatory Affairs Department, Pharmacovigilance and Quality Assurance Division, Kyowa Hakko Kirin Co., Ltd. |
| Mar. 2017 | Executive Officer Director, Regulatory Affairs Department, Kyowa Hakko Kirin Co., Ltd. |
| Mar. 2019 | Executive Officer Director, Corporate Strategy and Planning Department, Kyowa Hakko Kirin Co, Ltd. |
| Mar. 2021 | Managing Executive Officer Director, Corporate Strategy and Planning Department, Kyowa Kirin Co., Ltd. |
| Mar. 2022 | Managing Executive Officer Vice President, Head of Strategy Division, Kyowa Kirin Co., Ltd. |
| Mar. 2023 | Director of the Board, Senior Managing Executive officer, Head of Strategy Division, Kyowa Kirin Co., Ltd. |
| Apr. 2023 | Director of the Board, Senior Managing Executive officer, Kyowa Kirin Co., Ltd. |
| Apr. 2024 | Director of the Board, Senior Managing Executive officer & Chief Medical Officer(CMO), Kyowa Kirin Co., Ltd. |
| Mar. 2025 | Director of the Board, Executive Vice President & Chief Medical Officer(CMO), Kyowa Kirin Co., Ltd. (to present) |
- Daisuke Fujiwara, Ph.D. (Profile)
- Director
Daisuke Fujiwara, Ph.D. Profile
| Apr. 1995 | Joined Kirin Brewery Company, Limited（presently Kirin Holdings Company, Limited） |
|---|---|
| Feb. 2005 | Visiting Researcher, RIKEN Research Center for Allergy and Immunology |
| Sep. 2005 | Postdoctoral Fellow, David Geffen School of Medicine at UCLA（USA） |
| Nov. 2007 | Senior Researcher, Central Laboratories for Key Technologies, Kirin Holdings Company, Limited |
| May. 2014 | Part-time Lecturer, Graduate School of Agricultural and Life Sciences, The University of Tokyo（to present） |
| Mar. 2021 | General Manager, Health Science Department, Kirin Holdings Company, Limited |
| Mar. 2023 | Executive Officer and General Manager of Institute of Health Sciences, Kirin Holdings Company, Limited |
| Mar. 2025 | Director of the Board, Kyowa Kirin Co., Ltd.（to present） Senior Executive Officer, President of R&D Division, Kirin Holdings Company, Limited（to present） |
- Takashi Oyamada, MBA (Profile)
- Director
Takashi Oyamada, MBA Profile
| Apr. 1979 | Joined The Mitsubishi Bank, Limited (presently MUFG Bank, Ltd.) |
|---|---|
| Jan. 2006 | Executive Officer, The Bank of Tokyo-Mitsubishi UFJ, Ltd. (presently MUFG Bank, Ltd.) |
| Jan. 2009 | Managing Executive Officer, The Bank of Tokyo-Mitsubishi UFJ, Ltd. |
| Jun. 2009 | Managing Director, The Bank of Tokyo Mitsubishi UFJ, Ltd. Member of the Board of Directors, Mitsubishi UFJ Financial Group, Inc. |
| May. 2012 | Managing Executive Officer, The Bank of Tokyo-Mitsubishi UFJ, Ltd. |
| May 2013 | Senior Managing Executive Officer, The Bank of Tokyo-Mitsubishi UFJ, Ltd. |
| Jun. 2014 | Representative Director, Deputy President, The Bank of Tokyo-Mitsubishi UFJ, Ltd. |
| Jun. 2015 | Member of the Board of Directors, Representative Corporate Executive, Deputy President and COO, Mitsubishi UFJ Financial Group, Inc. |
| Apr. 2016 | Member of the Board of Directors, President & CEO, The Bank of Tokyo-Mitsubishi UFJ, Ltd. Member of the Board of Directors, Mitsubishi UFJ Financial Group, Inc. |
| Jun. 2017 | Senior Advisor, The Bank of Tokyo-Mitsubishi UFJ, Ltd. (to present) |
| Jun. 2018 | Director and Vice Chair, The Japan Institute of International Affairs (to present) |
| Dec. 2018 | Outside Director, Mitsubishi Research Institute DCS Co., Ltd. (to present) |
| Jun. 2019 | Outside Director, Mitsubishi Electric Corporation Outside Director, Isetan Mitsukoshi Holdings Ltd. |
| Mar. 2021 | Outside Director of the Board, Kyowa Kirin Co., Ltd. (to present) |
- Yoshihisa Suzuki, MBA (Profile)
- Director
Yoshihisa Suzuki, MBA Profile
| Apr. 1979 | Joined ITOCHU Corporation |
|---|---|
| Jun. 2003 | Executive Officer, ITOCHU Corporation |
| Apr. 2006 | Managing Executive Officer, ITOCHU Corporation Executive Vice President and CAO, ITOCHU International Inc. |
| Apr. 2007 | President and CEO, ITOCHU International Inc. |
| Jun. 2011 | Executive Vice President, JAMCO Corporation |
| Jun. 2012 | President and CEO, JAMCO Corporation |
| Jun. 2016 | Senior Managing Executive Officer, Member of the Board, ITOCHU Corporation |
| Apr. 2018 | President and Chief Operating Officer (COO), Member of the Board, ITOCHU Corporation |
| Apr. 2020 | President and Chief Operating Officer (COO), Chief Digital Officer (CDO), and Chief Information Officer (CIO), Member of the Board, ITOCHU Corporation |
| Apr. 2021 | Vice Chairman, Member of the Board, ITOCHU Corporation |
| Mar. 2022 | Outside Director of the Board, Kyowa Kirin Co., Ltd. (to present) |
| Apr. 2022 | Vice Chairman, ITOCHU Corporation |
| Jun. 2022 | Outside Director, OMRON Corporation (to present) |
| Apr. 2023 | Senior Vice Representative for External Affairs, ITOCHU Corporation |
| Apr. 2024 | Advisory Member, ITOCHU Corporation (to present) |
| Nov. 2024 | Representative Director, Rolling Hills, Co., Ltd. (to present) |
- Rumiko Nakata (Profile)
- Director
Rumiko Nakata Profile
| Apr. 1979 | Joined Esso Sekiyu K.K. |
|---|---|
| Apr. 1996 | Joined Center for Socio-Economic Research K.K. |
| Apr. 2000 | Joined Pfizer K.K. (Pfizer Japan) |
| Dec. 2011 | Head of HR and Global Operations, Pfizer K.K. |
| Mar. 2012 | Corporate Officer, Pfizer K.K. |
| Jan. 2014 | Director of the Board, Corporate Officer, Pfizer K.K. |
| Mar. 2018 | Executive Officer, Diversity & Inclusion, Mitsubishi Chemical Corporation. |
| Apr. 2019 | Managing Executive Officer, Supervising-Human Resources Department, Mitsubishi Chemical Corporation. |
| Apr. 2020 | Director of the Board, Managing Executive Officer, Supervising – Administration Dept., Public Relations Dept., Human Resources Dept., Mitsubishi Chemical Corporation. |
| Mar. 2023 | Outside Director of the Board, Kyowa Kirin Co., Ltd. (to present) |
| Jun. 2024 | Outside Director, Denka Company Limited(to present) |
- Hiroshi Kanno, MBA (Profile)
- Director
Hiroshi Kanno, MBA Profile
| Apr. 1983 | Joined Nikken Sekkei Ltd. |
|---|---|
| Aug. 1991 | Joined Boston Consulting Group, Inc.（presently Boston Consulting Group, LLC） |
| Jan. 2000 | Partner & Managing Director, Boston Consulting Group, Inc. （presently Boston Consulting Group, LLC） |
| Jul. 2008 | Professor, Hitotsubashi University Graduate School of International Corporate Strategy |
| Jun. 2011 | Outside Director, OMRON Healthcare Co., Ltd. |
| Apr. 2012 | Dean, Hitotsubashi University Graduate School of International Corporate Strategy |
| Jun. 2015 | Outside Auditor, STANLEY ELECTRIC Co., Ltd. |
| Sep. 2016 | Professor, Waseda Business School（Graduate School of Business and Finance）（to present） |
| Dec. 2016 | Director, Unicharm Kyoshin Foundation（to present） |
| Sep. 2017 | Outside Director, ERI Holdings Co., Ltd. |
| Sep. 2018 | Director, Waseda University Institute for Business and Finance（to present） |
| Apr. 2020 | Visiting Professor, The Open University of Japan（to present） |
| Jul. 2022 | Director, Laboro.AI Inc.（to present） |
| Feb. 2023 | Visiting Professor, School of Business, Aalto University（Finland） |
| Mar. 2025 | Outside Director of the Board, Kyowa Kirin Co., Ltd.（to present） |
- Yukiko Ito, Ph.D. (Profile)
- Director
Yukiko Ito, Ph.D. Profile
| Apr. 2006 | Assistant Professor, Faculty of Economics, Tokyo Keizai University |
|---|---|
| Apr. 2009 | Associate Professor, Department of Economics, Faculty of Humanities and Social Sciences, Tokyo Gakugei University |
| Jul. 2015 | Committee member, Committee for the Promotion of Integrated Economic and Fiscal Reforms, Cabinet Office |
| Apr. 2018 | Professor, College of Policy Studies, Tsuda University |
| Jul. 2018 | Subcommittee Member, Pharmaceuticals and Medical Devices System, Health Sciences Council, Ministry of Health, Labor and Welfare（to present） |
| Apr. 2024 | Director, Japan Community Healthcare Organization（to present） |
| Jun. 2024 | Director, Pfizer Health Research Foundation（to present） |
| Mar. 2025 | Outside Director of the Board, Kyowa Kirin Co., Ltd.（to present） |
| Apr. 2025 | Professor, Graduate School of Business and Commerce, Keio University（to present） |
Audit & Supervisory Board Members
Hiroshi Komatsu (Profile)
Hiroshi Komatsu Profile
| Apr. 1986 | Joined Kyowa Hakko Kogyo Co., Ltd. (presently Kyowa Kirin Co., Ltd.) |
|---|---|
| Feb. 2009 | CFO, Hematech, Inc. |
| Apr. 2012 | Manager, Corporate Planning Department, Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co., Ltd.) |
| Apr. 2015 | Deputy Director, General Affairs Department, Kyowa Hakko Kirin Co., Ltd. |
| Apr. 2016 | Deputy Director, General Affairs Department, and Leader, Corporate Secretariat Group, General Affairs Department, Kyowa Hakko Kirin Co., Ltd. |
| Mar. 2018 | Audit & Supervisory Board Member (Full-time), Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co., Ltd.) (to present) |
Hajime Kobayashi (Profile)
Hajime Kobayashi Profile
| Apr. 1989 | Joined Kirin Brewery Company, Limited (presently Kirin Holdings Company, Limited) |
|---|---|
| Apr. 2011 | Director, General Manager of Corporate Planning, Interfood Shareholdings Company (Vietnam) |
| Jan. 2013 | Deputy Director, Corporate Strategy, Kirin Holdings Company, Limited |
| Apr. 2018 | Head of Global Personnel Section, Personnel & General Affairs, Kirin Holdings Company, Limited |
| Mar. 2020 | General Manager, Internal Audit Dept, Kirin Holdings Company, Limited |
| Mar. 2022 | Executive Officer, General Manager, Internal Audit Dept, Kirin Holdings Company, Limited |
| Mar. 2024 | Outside Audit & Supervisory Board Member (Full-time), Kyowa Kirin Co., Ltd. (to present) |
Mayumi Tamura (Profile)
Mayumi Tamura Profile
| Apr. 1983 | Joined Sony Corporation (presently Sony Group Corporation) |
|---|---|
| Sep. 1991 | Joined JOHNSON COMPANY, LIMITED |
| Jul. 2002 | Executive Officer, Johnson Diversey Co. Ltd. (presently CxS Corporation) |
| Dec. 2004 | CFO, adidas Japan K.K. |
| Jun. 2007 | Executive Officer, Senior Vice President and CFO, Seiyu KK |
| May. 2010 | Executive Officer, SVP and CFO, Walmart Japan Holdings GK (presently Seiyu Holdings Company, Limited) Executive Officer, SVP and CFO, Seiyu GK (presently Seiyu KK) |
| Jun. 2015 | Outside Corporate Auditor, Honda Motor Co., Ltd. |
| Jun. 2017 | Outside Director, Honda Motor Co., Ltd. Outside Director, Hitachi High-Technologies Corporation (presently Hitachi High-Tech Corporation) |
| Jun. 2019 | Outside Director, SHIMIZU CORPORATION (to present) |
| Mar. 2022 | Outside Audit & Supervisory Board Member, Kyowa Kirin Co., Ltd. (to present) |
| Jun. 2022 | Outside Director, LIXIL Corporation(to present) |
Toru Ishikura (Profile)
Toru Ishikura Profile
| Apr. 1989 | Joined Kirin Brewery Company, Limited (presently Kirin Holdings Company, Limited) |
|---|---|
| Mar. 2015 | General Manager, Technology Management Department, Research & Development Division, Kirin Company, Limited (presently Kirin Holdings Company, Limited) |
| Apr. 2015 | General Manager, Research & Development Strategy Department, Research & Development Division, Kirin Company, Limited |
| Mar. 2018 | Executive Officer, General Manager, Research & Development Strategy Department, Research & Development Division, Kirin Company, Limited |
| Apr. 2019 | Executive Officer, Vice President of Research & Development Division and General Manager, Research & Development Strategy Department, Research & Development Division, Kirin Holdings Company, Limited |
| Mar.- Apr. 2020 | Director of the Board, KYOWA HAKKO BIO CO. LTD. Executive Officer, General Manager, Health Business Strategy Office, Corporate Strategy Department, Kirin Holdings Company, Limited |
| Apr. 2022 | Executive Officer, General Manager, Health Science Business Department, Health Science Business Division, Kirin Holdings Company, Limited |
| Mar. 2023 | Audit & Supervisory Board Member, Kyowa Kirin Co., Ltd. (to present) Company Auditor (Full-time), Kirin Holdings Company, Limited (to present) |
Yoko Wachi (Profile)
Yoko Wachi Profile
| Apr. 1989 | Joined Kajitani Law Offices Admitted in Japan（Dai-Ichi Tokyo Bar Association） |
|---|---|
| Apr. 2006 | Mediator of Family Conciliations, Tokyo Family Court（to present） |
| Jun. 2015 | Outside Audit & Supervisory Board Member of NICHIAS CORPORATION |
| Mar. 2016 | Outside Audit & Supervisory Board Member of Otsuka Holdings Co., Ltd. |
| Jan. 2019 | Partner, Kajitani Law Offices（to present） |
| Apr. 2019 | Vice President of the Tokyo Association of Family Conciliations |
| Jun. 2019 | Outside Director of NICHIAS CORPORATION（to present） |
| Jun. 2023 | Outside Director of S.T. CORPORATION（to present） |
| Mar. 2025 | Outside Audit & Supervisory Board Member, Kyowa Kirin Co., Ltd.（to present） |
One Kyowa Kirin Leadership
- Masashi Miyamoto, Ph.D. (Profile)
- Chief Executive Officer (CEO) and Region President, JAPAC
Masashi Miyamoto, Ph.D. Profile
| Apr. 1985 | Joined Kirin Brewery Company, Limited (presently Kirin Holdings Company, Limited) |
|---|---|
| Apr. 2011 | Director, Regulatory Affairs Department, Pharmacovigilance and Quality Assurance Division, Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co., Ltd.) |
| Mar. 2012 | Executive Officer, Director, Regulatory Affairs Department, Pharmacovigilance and Quality Assurance Division, Kyowa Hakko Kirin Co., Ltd. |
| Jul. 2014 | Executive Officer, Director, Strategic Product Portfolio Department and Regulatory Affairs Department, Pharmacovigilance and Quality Assurance Division, Kyowa Hakko Kirin Co., Ltd. |
| Apr. 2015 | Executive Officer, Director, Strategic Product Portfolio Department, Kyowa Hakko Kirin Co., Ltd. |
| Mar. 2017 | Director of the Board, Managing Executive Officer, Strategic Product Portfolio Department, Kyowa Hakko Kirin Co., Ltd. |
| Apr. 2017 | Director of the Board, Managing Executive Officer, Director, Corporate Strategy & Planning Department, Kyowa Hakko Kirin Co., Ltd. |
| Mar. 2018 | Representative Director of the Board, President, Kyowa Hakko Kirin Co., Ltd. |
| Apr. 2024 | Representative Director of the Board, President & Chief Executive Officer(CEO), Kyowa Kirin Co., Ltd. |
| Mar. 2025 | Representative Director of the Board, Chairman & Chief Executive Officer(CEO), Kyowa Kirin Co., Ltd. (to present) |
- Abdul Mullick, Ph.D. (Profile)
- Chief Operating Officer (COO)
Abdul Mullick, Ph.D. Profile
| Jan. 1999 | Global Marketing Director, Diabetes, Hoechst Marion Roussel Ltd. (presently Sanofi-Aventis Pharma AG) |
|---|---|
| Jan. 2005 | Senior Global Brand Director, Diabetes, Novartis Pharma AG |
| Dec. 2007 | EMEA Business Unit Head, Genzyme Corp. |
| Jan. 2009 | Vice President Commercial Operations – Japan, Asia-Pac, Australia & China, Genzyme Corp. |
| Jan. 2011 | Vice President, Head of Global Marketing, Rare Diseases, Genzyme Corp. |
| Jul. 2013 | Vice President & General Manager, Endocrinology and Cardiology, Rare Diseases, Genzyme USA |
| Sep. 2014 | Executive Vice President, Head of Global Marketing, Vifor Pharma Ltd |
| Mar. 2018 | Executive Vice President, Rare Disease Head, Kyowa Kirin International plc |
| Apr. 2019 | President, Kyowa Kirin International plc |
| Jan. 2023 | Managing Executive Officer, Vice Chief International Business Officer, Kyowa Kirin Co., Ltd. |
| Mar. 2023 | Managing Executive Officer, Chief International Business Officer, Kyowa Kirin Co., Ltd. |
| Apr. 2024 | Managing Executive Officer, Chief International Business Officer (CIBO), Kyowa Kirin Co., Ltd. |
| Mar. 2025 | Representative Director of the Board, President and Chief Operating Officer (COO) (to present) |
- Takeyoshi Yamashita, Ph.D. (Profile)
- Chief Medical Officer (CMO)
Takeyoshi Yamashita, Ph.D. Profile
| Apr. 1987 | Joined Kirin Brewery Company, Limited (presently Kirin Holdings Company, Limited) |
|---|---|
| Apr. 2010 | Director, Innovative Drug Discovery Laboratories, Research Division, Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co., Ltd.) |
| Apr. 2012 | Director, Research Planning Department, Research Division, Kyowa Hakko Kirin Co., Ltd. |
| Apr. 2015 | Director, Regulatory Affairs Department, Pharmacovigilance and Quality Assurance Division, Kyowa Hakko Kirin Co., Ltd. |
| Mar. 2017 | Executive Officer Director, Regulatory Affairs Department, Kyowa Hakko Kirin Co., Ltd. |
| Mar. 2019 | Executive Officer Director, Corporate Strategy and Planning Department, Kyowa Hakko Kirin Co, Ltd. |
| Mar. 2021 | Managing Executive Officer Director, Corporate Strategy and Planning Department, Kyowa Kirin Co., Ltd. |
| Mar. 2022 | Managing Executive Officer Vice President, Head of Strategy Division, Kyowa Kirin Co., Ltd. |
| Mar. 2023 | Director of the Board, Senior Managing Executive officer, Head of Strategy Division, Kyowa Kirin Co., Ltd. |
| Apr. 2023 | Director of the Board, Senior Managing Executive officer, Kyowa Kirin Co., Ltd. |
| Apr. 2024 | Director of the Board, Senior Managing Executive officer & Chief Medical Officer(CMO), Kyowa Kirin Co., Ltd. |
| Mar. 2025 | Director of the Board, Executive Vice President & Chief Medical Officer(CMO), Kyowa Kirin Co., Ltd. (to present) |
- Tomohiro Sudo, M.S, MBA (Profile)
- Chief International Business Officer (CIBO)
Tomohiro Sudo, M.S, MBA Profile
| Apr. 1993 | Joined Kirin Brewery Company, Limited (presently Kirin Holdings Company, Ltd.) |
|---|---|
| Feb. 2001 | Manager, Clinical Development, GEMINI SCIENCE, INC. (California, USA) |
| Apr. 2004 | Vice President, GEMINI SCIENCE, INC. (California, USA) |
| Sep. 2009 | Manager, Group No.2, Strategic Product Department, Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co., Ltd.) |
| Apr. 2014 | Deputy Director, Strategic Product Portfolio Department, Kyowa Hakko Kirin Co., Ltd |
| Apr. 2016 | Global Product Lead for Crysvita, Kyowa Kirin International Plc (UK) |
| Jan. 2017 | Executive Vice President of Kyowa Kirin International Plc (UK) |
| Apr. 2020 | Executive Officer Director, Strategic Product Planning Department, Kyowa Kirin Co., Ltd. |
| Apr. 2021 | Executive Officer Director, Global Product Strategy Department, Kyowa Kirin Co., Ltd. (to present) |
| Apr. 2022 | Executive Officer Director, Global Product Strategy Department, Strategy Division, Kyowa Kirin Co., Ltd. |
| Apr. 2024 | Executive Officer Director, Global Product Strategy Department, Kyowa Kirin Co., Ltd. |
| Mar. 2025 | Managing Executive Officer and Chief International Business Officer (CIBO), Kyowa Kirin Co., Ltd.(to present) |
- Yasuo Fujii, MBA (Profile)
- Chief Strategy Officer (CSO)
Yasuo Fujii, MBA Profile
| Apr. 1988 | Joined Kyowa Hakko Kogyo Co.,Ltd. (presently Kyowa Kirin Co., Ltd.) |
|---|---|
| Sep. 2011 | Senior Vice President, ProStrakan, plc (presently Kyowa Kirin International, plc) |
| Sep. 2012 | Executive Vice President, ProStrakan, plc |
| Jan. 2017 | Deputy Director, Overseas Business Department, Kyowa Hakko Kirin (presently Kyowa Kirin Co.,Ltd.) |
| Mar. 2018 | Executive Officer Director, Business Development, Kyowa Hakko Kirin Co., Ltd. |
| Mar. 2023 | Managing Executive Officer Director, Business Development, Kyowa Kirin Co., Ltd. |
| Apr. 2023 | Managing Executive Officer, Vice President, Head of Strategy Division, Kyowa Kirin Co., Ltd. |
| Apr. 2024 | Managing Executive Officer and Chief Strategy Officer (CSO), Kyowa Kirin Co., Ltd. (to present) |
- Mitsuru Kameyama (Profile)
- Chief Digital Transformation Officer (CDXO)
Mitsuru Kameyama Profile
| Apr. 1980 | Joined Nissan Motor Co., Ltd., |
|---|---|
| Apr. 2005 | Head of Information Systems Division, Dongfeng Motor Corporation (a joint venture in China) |
| Apr. 2012 | General Manager of the Information Planning Department, Shiseido Company, Limited |
| Apr. 2013 | President and CEO, Shiseido Information Network Co., Ltd. |
| Jan. 2016 | Executive Officer and CITO (Chief Information Technology Officer), Shiseido Company, Limited |
| Feb. 2020 | CDO (Chief Digital Officer), Mitsubishi Materials Corporation |
| Jan. 2023 | Senior Executive Advisor, Globe-ing Inc. |
| Apr. 2025 | Executive Officer Chief Digital Transformation Officer (CDXO) and Head of ODX Department, Kyowa Kirin Co., Ltd. (to present) |
- Yoshiko Mori (Profile)
- Chief Compliance Officer (CCO)
Yoshiko Mori Profile
| Apr. 1992 | Joined Kyowa Hakko Kogyo Co., Ltd.(presently Kyowa Kirin Co., Ltd.) |
|---|---|
| Apr. 2009 | Manager of Pharmacovigilance, Kyowa Hakko Kirin Co., Ltd.(presently Kyowa Kirin Co., Ltd.) |
| Oct. 2009 | Manager of Human resources, Kyowa Hakko Kirin Co., Ltd. |
| Apr. 2014 | Senior manager, Pharmacovigilance Division, Kyowa Hakko Kirin Co., Ltd. |
| Sep. 2019 | Director of Pharmacovigilance, Kyowa Hakko Kirin Co., Ltd. |
| Jan. 2020 | Vice Division Head of Pharmacovigilance, Kyowa Kirin Co., Ltd. |
| Dec. 2021 | Vice President, Head of Pharmacovigilance Division, Kyowa Kirin Co., Ltd. |
| Mar. 2022 | Executive Officer Vice President, Head of Pharmacovigilance Division, Kyowa Kirin Co., Ltd. |
| Mar. 2024 | Executive Officer Director, CSR Management Department, Kyowa Kirin Co., Ltd. Marketing Supervisor-General, Kyowa Kirin Co., Ltd. (to present) |
| Mar. 2025 | Managing Executive Officer and Chief Compliance Officer (CCO), Kyowa Kirin Co., Ltd. (to present) |
- Motohiko Kawaguchi (Profile)
- Chief Financial Officer (CFO)
Motohiko Kawaguchi Profile
| Apr. 1986 | Joined Kyowa Hakko Kogyo Co., Ltd. (presently Kyowa Kirin Co., Ltd.) |
|---|---|
| Mar. 2012 | Director, Accounting Department, Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co., Ltd.) |
| Mar. 2018 | Executive Officer Director, Accounting Department, Kyowa Hakko Kirin Co., Ltd. |
| Jul. 2019 | Executive Officer Director, Finance Department, Kyowa Kirin Co., Ltd. |
| Mar. 2022 | Managing Executive Officer Director, Finance Department, Kyowa Kirin Co., Ltd. |
| Apr. 2024 | Managing Executive Officer and Chief Financial Officer (CFO) Kyowa Kirin Co., Ltd. (to present) |
- Shoko Itagaki (Profile)
- Chief People Officer (CPO) & Global Human Resources Head
Shoko Itagaki Profile
| Apr. 1995 | Joined Kirin Brewery Company, Limited (presently Kirin Holdings Company, Limited) |
|---|---|
| Mar. 2019 | Director, Regulatory Affairs Department, Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co., Ltd.) |
| Mar. 2021 | Executive Officer Director, Corporate Strategy & Planning Department, Kyowa Kirin Co., Ltd. |
| Apr. 2022 | Executive Officer Director, Corporate Planning Department, Strategy Division, Kyowa Kirin Co., Ltd. |
| Apr. 2024 | Executive Officer and Chief People Officer (CPO), Kyowa Kirin Co., Ltd. |
| Mar. 2025 | Managing Executive Officer and Chief People Officer (CPO), Kyowa Kirin Co., Ltd. (to present) |
- Toshiyuki Kurata, MBA (Profile)
- Chief Supply Chain Officer (CSCO) & Global Manufacturing Head
Toshiyuki Kurata, MBA Profile
| Apr. 1995 | Joined Kirin Brewery Company, Limited (presently Kirin Holdings Company, Limited) |
|---|---|
| Apr. 2016 | Director, Bio Process Research and Development Laboratories, Production Division, Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co., Ltd.) |
| Apr. 2019 | Director, Production Planning department, Production Division, Kyowa Hakko Kirin Co., Ltd. |
| Apr. 2021 | Executive Officer Vice Head of Production Division & Director, Production Planning Department, Kyowa Kirin Co., Ltd. |
| Apr. 2022 | Executive Officer Vice President, Head of Production Division, Kyowa Kirin Co., Ltd. |
| Apr. 2024 | Executive Officer, Chief Supply Chain Officer (CSCO) & Vice President, Head of Production Division, Kyowa Kirin Co., Ltd. |
| Apr. 2025 | Managing Executive Officer and Chief Supply Chain Officer (CSCO), Kyowa Kirin Co., Ltd. (to present) |
- Hiroshi Sonekawa (Profile)
- Japan Sales & Marketing Head
Hiroshi Sonekawa Profile
| Apr. 1985 | Joined Kyowa Hakko Kogyo Company, Limited (presently Kyowa Kirin Company, Limited) |
|---|---|
| Apr. 2010 | Deputy Director, Tokyo Branch, Sales & Marketing Division, Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Company, Limited) |
| Apr. 2011 | Director, Keiji-Hokuriku Branch, Sales & Marketing Division, Kyowa Hakko Kirin Co., Ltd. |
| Mar. 2013 | Director, Nagoya Branch, Sales & Marketing Division, Kyowa Hakko Kirin Co., Ltd. |
| Apr. 2015 | Executive Officer Director, Area Marketing Strategy Department, Sales & Marketing Division, Kyowa Hakko Kirin Co., Ltd. |
| Jan. 2020 | Executive Officer Director, Internal Audit Department, Kyowa Kirin Co., Ltd. |
| Mar. 2021 | Executive Officer Vice President, Head of Sales & Marketing Division, Kyowa Kirin Co., Ltd. |
| Mar. 2022 | Managing Executive Officer Vice President, Head of Sales & Marketing Division, Kyowa Kirin Co., Ltd. (to present) |
- Steve Schaefer, MBA (Profile)
- Region President, North America
Steve Schaefer, MBA Profile
| May. 1991 | Captain, United States Marine Corps |
|---|---|
| Jan. 1997 | Primary Care and Neuroscience Sales Representative, Eli Lilly and Company, USA |
| Dec. 1998 | Market Research Associate, New Antidepressant Team, Eli Lilly and Company, USA |
| Jan. 2001 | Depression Commercialization Manager, Neurosciences, Cymbalta, USA, Eli Lilly and Company, USA |
| Oct. 2004 |
Eli Lilly and Company, USA |
| Jul. 2017 |
Takeda Pharmaceuticals, USA |
| Apr. 2023 | President, KKNA Director on Board of Directors, Kyowa Kirin USA Holdings, Inc. & Kyowa Kirin, Inc. (KKNA) (to present) |
- Jeremy Morgan (Profile)
- Region President, Europe and the Rest of the World
Jeremy Morgan Profile
| Sep. 1986 | Sales and Marketing Positions (National, Regional and Global), Eli Lilly and Company |
|---|---|
| Sep. 2003 | Managing Director, Turkey, Eli Lilly and Company |
| Mar. 2007 | General Manager & Vice President, Australia & New Zealand, Eli Lilly and Company |
| Mar. 2010 | General Manager & VP, Germany, Austria, Switzerland, Eli Lilly and Company |
| Apr. 2014 | Vice President, Diabetes, International, Eli Lilly and Company |
| Apr. 2015 | Executive sponsor of the European Gender Inclusion Network, Eli Lilly and Company |
| Jan. 2019 | Chairman (non exec), PHMR, an international team of highly qualified health economists and research scientists |
| May. 2020 | Senior Vice President Commercial, Kyowa Kirin International plc |
| Jun. 2021 | NED and Chair RemCom, Arecor Therapeutics (to present) |
| Jan. 2023 | President, Kyowa Kirin International plc (to present) |
- Toshiaki Uchikawa (Profile)
- Global International Business Planning Head
Toshiaki Uchikawa Profile
| Sep. 2003 | Joined Kirin Brewery Company, Limited (presently Kirin Holdings Company, Limited) |
|---|---|
| Apr. 2019 | Director, Overseas Business Planning Department, Kyowa Kirin Co., Ltd. (to present) |
- Takefumi Matsushita, Ph.D., MBA (Profile)
- Global Corporate Planning Head
Takefumi Matsushita, Ph.D., MBA Profile
| Apr. 1999 | Joined Kyowa Hakko Kogyo Co., Ltd. (presently Kyowa Kirin Co., Ltd.) as a staff scientist |
|---|---|
| Jun. 2002 | Sent to BioWa, Inc., a US subsidiary specialized in technology licenses; Director and Head of Business Development since 2007 |
| Dec. 2010 | Manager, Clinical Development, Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co., Ltd.) |
| Apr. 2013 | Sent to Kyowa Kirin Pharmaceutical Development, Inc. in the US; Director and Head of Planning since 2014 |
| Apr. 2018 | Deputy Director, Business Development & Head of Alliance Excellence ,Kyowa Hakko Kirin Co., Ltd. |
| Jul. 2019 | Sent to Kirin Holdings Company Limited; Deputy general Manager, Corporate Strategy |
| Mar. 2022 | Director, Medical Affairs Department, Kyowa Kirin Co., Ltd |
| Mar. 2023 | Executive officer, Director, Medical Affairs Department, Kyowa Kirin Co., Ltd. |
| Apr. 2024 | Executive officer Director, Corporate Planning Department, Kyowa Kirin Co., Ltd. (to present) |
- Hideaki Matsumoto, MBA (Profile)
- Global Product Strategy Head
Hideaki Matsumoto, MBA Profile
| Apr. 1997 | Joined Kirin Brewery Company, Limited（presently Kirin Holdings Company, Limited） |
|---|---|
| May. 2014 | Managing Director, Kyowa Hakko Kirin Singapore Pte. Ltd. |
| May. 2018 | Manager, Internal Audit Department, Kyowa Hakko Kirin Co., Ltd.（presently Kyowa Kirin Co., Ltd.） |
| Sep. 2021 | Vice President, Global Crysvita Sales & Marketing Lead, Kyowa Kirin, Inc.（KKNA） |
| Jan. 2023 | Senior Vice President, Global Crysvita Franchise Head, Kyowa Kirin, Inc.（KKNA） |
| Mar. 2025 | Executive Officer Director, Global Product Strategy Department, Kyowa Kirin Co., Ltd.（to present） |
- Wayne Bowler, Ph.D. (Profile)
- Global Business Development Head
Wayne Bowler, Ph.D. Profile
| 1999 | Fellow, Arthritis Research Council UK |
|---|---|
| 2001 | Research Lead Bone & Skin, Strakan Pharmaceuticals |
| 2005 | Business Development Manager, Prostrakan Pharmaceuticals |
| 2008 | Business Development Director, Prostrakan Parmaceuticals |
| 2010 | VP Business Development, Prostrakan Pharmaceuticals |
| 2012 | Senior VP Business Development, Kyowa Kirin International plc (to present) |
- Nathan Hawes, MBA (Profile)
- Global Operational and Digital Transformation Head
Nathan Hawes, MBA Profile
| Jun. 1993 | Joined SmithKline Beecham (presently GlaxoSmithKline) |
|---|---|
| Apr. 1999 | Planning & IT Director, SmithKline Beecham (presently GlaxoSmithKline) |
| Mar. 2005 | Supply Chain Strategy Director, GlaxoSmithKline |
| Jan. 2007 | Supply Chain & ERP Transformation Head, GlaxoSmithKline (Japan) |
| Jun. 2013 | Global Supply Chain Transformation Head, GlaxoSmithKline (Singapore) |
| Dec. 2016 | Regional Head of Supply Chain, Europe, GlaxoSmithKline |
| Jan. 2019 | Regional Head of Supply Chain, Kyowa Kirin International plc. |
| Oct. 2023 | Head of Global Business Transformation, Kyowa Kirin Co., Ltd. |
| Apr. 2025 | Global Operational & Digital Transformation Head, Kyowa Kirin Co., Ltd. (to present) |
- Takuo Hirose (Profile)
- Global Information and Communication Technology Head
Takuo Hirose Profile
| Oct. 2018 | Joined Kyowa Hakko Kirin Co., Ltd.(presently Kyowa Kirin Co., Ltd.) |
|---|---|
| Apr. 2019 | Director, ICT Solution Department, Kyowa Hakko Kirin Co., Ltd.(presently Kyowa Kirin Co., Ltd.) (to present) |
- Takaaki Uochi, Ph.D. (Profile)
- Global Corporate Social Responsibility (CSR) Head
Takaaki Uochi, Ph.D. Profile
| Apr. 1998 | Joined Kyowa Hakko Kogyo Co., Ltd. (presently Kyowa Kirin Co., Ltd.) as a staff scientist |
|---|---|
| Apr. 2010 | Manager, Human Resources Department, Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co., Ltd.) |
| Apr. 2017 | Manager, Corporate Strategy Planning Department, Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co., Ltd.) |
| Apr. 2021 | Deputy Director and Head of Secretarial group, Human Resources Department, Kyowa Kirin Co., Ltd. |
| Jun. 2023 | Representative Director of the Board, President, Kyowa Kirin Korea Co., Ltd. |
| Mar. 2025 | Director, CSR Management Department, Kyowa Kirin Co., Ltd. (to present) |
- Kazuki Nemoto (Profile)
- Global Legal Head
Kazuki Nemoto Profile
| Apr. 1994 | Joined Kirin Brewery Company, Limited (presently Kirin Holdings Company, Limited) |
|---|---|
| Apr. 2014 | Deputy Director, Legal Department, Kirin Holdings Company, Limited |
| Jan. 2022 | General Manager, Legal Department, Kirin Holdings Company, Limited |
| Oct. 2022 | Deputy Director, Legal and Intellectual Property Department, Kyowa Kirin Co., Ltd. |
| Apr. 2023 | Director, Legal Department, Kyowa Kirin Co., Ltd. (to present) |
- Ian Duguid PhD, MRPharmS (Profile)
- Global Regulatory Affairs Head
Ian Duguid PhD, MRPharmS Profile
| Oct. 1992 | Registration Scientist, Bayer Plc |
|---|---|
| May. 1995 | Scientific and Regulatory Affairs Manager, Bausch & Lomb Inc |
| Jun. 1996 | Senior Registration Manager, British Biotech Pharmaceutical Ltd |
| Apr. 1999 | Regulatory Affairs Director, Knoll Ltd |
| Jul. 2002 | Head of Regulatory Affairs, Strakan Pharmaceuticals Ltd |
| Apr. 2010 | Senior VP Regulatory Affairs, Prostrakan Ltd/ Kyowa Kirin International plc |
| Feb. 2020 | Global Regulatory Affairs Head, Kyowa Kirin International plc (to present) |
- Jonathan Patroni, MBA (Profile)
- Global Quality Assurance Head
Jonathan Patroni, MBA Profile
| Jan. 1996 | QA Process Analyst, Merck Pharmaceuticals, Merck Manufacturing Division |
|---|---|
| Nov. 1998 | Production Supervisor, Merck Pharmaceuticals, Merck Manufacturing Division |
| Nov. 2001 | QA Manager, QA Technical Services; Product Disposition; Compliance and Validation, Johnson & Johnson Pharmaceuticals |
| Feb. 2008 | QA Director, Global Compliance & Quality Systems, Wyeth/Pfizer Pharmaceuticals |
| May. 2009 | Senior Director, Quality Systems; Global QA External Supply, Shire/Takeda Pharmaceuticals |
| Jan. 2013 | Vice President, Global QA External Supply, Shire/Takeda Pharmaceuticals |
| Oct. 2013 | Vice President, QA Internal/External, Biological & Small Molecules, Shire/Takeda Pharmaceuticals |
| Apr. 2016 | Vice President Quality, Shire/Takeda Pharmaceuticals |
| Feb. 2019 | Global Quality Assurance Head, Kyowa Kirin, Inc. (KKNA) (to present) |
- Yoshifumi Torii, Ph.D. (Profile)
- Global Research Head
Yoshifumi Torii, Ph.D. Profile
| Apr. 1994 | Joined Kirin Brewery Company, Limited (presently Kirin Holdings Company, Limited) |
|---|---|
| Oct. 2017 | President & CEO, Fujifilm Kyowa Kirin Biologics Co., Ltd. |
| Oct. 2019 | Deputy Director, Business Planning Department, Kyowa Kirin Co., Ltd. |
| Mar. 2020 | Executive Officer Vice President, Head of R&D Division, Kyowa Kirin Co., Ltd. |
| Jan. 2024 | Executive Officer Vice President, Head of Research Division, Kyowa Kirin Co., Ltd. (to present) |
- Ernesto Aycardi (Profile)
- Global Development Head
Ernesto Aycardi Profile
| Dec. 1991 | Clinical Neurologist. Military Hospital Bogota Colombia |
|---|---|
| Jul. 2006 | Senior Director Worldwide Clinical Research Merck & Co |
| Jul. 2012 | Medical Director, Neurodegeneration, Pain and Peripheral nerve disorders Biogen Idec |
| Nov. 2013 | Head Late development Neurology Fertility Endocrinology EMD Serono, Inc |
| Mar. 2016 | Vice president TA head Migraine and Headache Teva Pharmaceuticals |
| Dec. 2017 | Vice president Head Clinical Operations, DM, Biometrics and Clinical Pharmacology Teva Pharmaceuticals |
| Mar. 2018 | Chief Medical Officer Xenon Pharmaceuticals |
| Apr. 2021 | Chief Development Officer, Kyowa Kirin Inc. (KKNA) (to present) |
- Eslie Dennis, MD, MBChB, FCP(SA) (Profile)
- Global Medical Affairs Head
Eslie Dennis, MD, MBChB, FCP(SA) Profile
| Jan. 1987 | Physician, Mpilo and Central Hospitals, Zimbabwe; Groote Schuur Hospital, South Africa |
|---|---|
| Jun. 1997 | Medical Advisor, Merck, Sharp and Dohme South Africa |
| Jul. 1998 | Medical Director and Medical Head South Africa, Novartis South Africa |
| Jul. 2000 | Global Communications Manager, Novartis Switzerland |
| Aug. 2001 | Sr Medical Dir. Gastroenterology; Exec. Director & Head: Medical Information & Comms; Exec. Director & Head: Safety Risk Management; Vice President & Medical Head Northeast, Novartis US |
| Oct. 2010 | Exec. Director PKD Consortium and Predictive Safety Testing Consortium, Critical Path Institute |
| Jan. 2012 | Vice President Global Scientific Affairs/Medical Affairs, Roche Tissue Diagnostics, Tucson AZ |
| May. 2021 | Chief Medical Officer, Senior Vice President and Head North America Medical Affairs, Kyowa Kirin, Inc. (KKNA) |
| Mar. 2024 | Global Medical Affairs Head, Kyowa Kirin, Inc. (KKNA) (to present) |
- Nilay Gami (Profile)
- Global Pharmacovigilance Head
Nilay Gami Profile
| Dec. 2001 | Pharmacist & Pharmacy Manager, Ahold USA |
|---|---|
| Mar. 2007 | Diabetes, Metabolic, Ophthalmology Therapeutic Area , Benefit & Risk Management, Pfizer |
| Nov. 2010 | Senior Safety Officer (US), Worldwide Safety, Pfizer |
| Aug. 2013 | Team Leader, Global Operations, Worldwide Safety, Pfizer |
| Nov. 2015 | Global Head Case Management, Office of Consumer Medical Safety, Johnson & Johnson |
| Apr. 2020 | Global Head, Pharmacovigilance Operations, North America, Head of Pharmacovigilance, Kyowa Kirin, Inc. (KKNA) |
| Sep. 2023 | Global Pharmacovigilance Head, Kyowa Kirin Co., Ltd. (to present) |
- Ikuko Okubo, MBA (Profile)
- Global Intellectual Property Head
Ikuko Okubo, MBA Profile
| Apr. 1993 | Joined Kyowa Hakko Kogyo Co., Ltd.(presently Kyowa Kirin Co., Ltd.) |
|---|---|
| Apr. 2012 | Senior Manager, Intellectual Property Department, Kyowa Hakko Kirin Co., Ltd.(presently Kyowa Kirin Co., Ltd.) |
| Apr. 2015 | Manager, Corporate Strategy and Planning Department, Kyowa Hakko Kirin Co., Ltd. |
| Apr. 2017 | Deputy Director, Legal and Intellectual Property Department, Kyowa Hakko Kirin Co., Ltd. |
| Apr. 2022 | Director, Legal and Intellectual Property Department, Kyowa Kirin Co., Ltd. |
| Apr. 2023 | Director, Intellectual Property Department, Kyowa Kirin Co., Ltd. |
| Mar. 2025 | Executive Officer Director, Intellectual Property Department, Kyowa Kirin Co., Ltd. (to present) |
- Naohiko Kubo (Profile)
- Global Finance Head
Naohiko Kubo Profile
| Apr. 1996 | Joined Kyowa Hakko Kogyo Co., Ltd. (presently Kyowa Kirin Co., Ltd.) |
|---|---|
| Apr. 2024 | Director, Finance Department, Kyowa Kirin Co., Ltd. |
| Mar. 2025 | Executive Officer Director, Finance Department, Kyowa Kirin Co., Ltd. (to present) |
- Hiroki Nakamura (Profile)
- Global Corporate Communications Head
Hiroki Nakamura Profile
| Apr. 1996 | Joined Kirin Brewery Company, Limited (presently Kirin Holdings Company, Limited) |
|---|---|
| Oct. 2012 | Manager, Public Relations Group, Corporate Communications Department Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co., Ltd.) |
| Apr. 2024 | Director, Corporate Communications Department, Kyowa Kirin Co., Ltd. (to present) |
- Masahiro Hara, MBA (Profile)
- Global Procurement Head
Masahiro Hara, MBA Profile
| Apr. 1996 | Joined Kyowa Hakko Kogyo Co., Ltd. (presently Kyowa Kirin Co., Ltd.) |
|---|---|
| Apr. 2010 | Treasurer, Kyowa Hakko Kirin America Inc. |
| Oct. 2020 | Deputy Director, Business Development, Kyowa Hakko Kirin Co., Ltd. |
| Nov. 2021 | Senior Manager, Corporate Planning, Kirin Holdings Co., Ltd. |
| Apr. 2024 | Director, Procurement Department, Kyowa Kirin Co., Ltd. (to present) |
- Emi Arakawa, Ph.D. (Profile)
- Global General Affairs Head
Emi Arakawa, Ph.D. Profile
| Apr. 1992 | Joined Kyowa Hakko Kogyo Co., Ltd. (presently Kyowa Kirin Co., Ltd.) |
|---|---|
| Apr. 2017 | Director, Fuji Research Park, R&D Division, Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co., Ltd.) |
| Apr. 2021 | Director, General Affairs Department, Kyowa Kirin Co., Ltd. (to present) |
- Atsushi Matsumoto, Ph.D. (Profile)
- Global Supply Chain Management Head
Atsushi Matsumoto, Ph.D. Profile
| Apr. 1993 | Joined Kirin Brewery Company, Limited (presently Kirin Holdings Company, Limited) |
|---|---|
| Oct. 2017 | Director, CMC Development Department, Production Division, Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co., Ltd.) |
| Jan. 2020 | President and CEO, Fujifilm Kyowa Kirin Biologics Co., Ltd. |
| Mar. 2022 | Executive Officer, Kyowa Kirin Co., Ltd. President and CEO, Fujifilm Kyowa Kirin Biologics Co., Ltd. |
| Mar. 2023 | Executive Officer, Director, Supply Chain Management Department, Kyowa Kirin Co., Ltd. (to present) |
- Kenji Shibata, Ph.D. (Profile)
- Global Internal Audit Head
Kenji Shibata, Ph.D. Profile
| Apr. 1992 | Joined Kyowa Hakko Kogyo Co, Ltd. (presently Kyowa Kirin Co, Ltd.) |
|---|---|
| Apr. 2004 | Senior Research Scientist, Tokyo Res. Labs., Kyowa Hakko Kogyo Co., Ltd. |
| Jul. 2009 | Manager, Research Planning Dept., Research Div., Kyowa Hakko Kirin Co., Ltd. (presently Kyowa Kirin Co, Ltd.) |
| Apr. 2012 | Group Head, Discovery Res. Labs., Research Div., Kyowa Hakko Kirin Co., Ltd. |
| Apr. 2014 | Group Head, R&D Planning Dept., R&D Div., Kyowa Hakko Kirin Co., Ltd. |
| Apr. 2016 | Deputy Director, R&D Planning Dept., R&D Div., Kyowa Hakko Kirin Co., Ltd. |
| Apr. 2018 | Director, R&D Planning Dept., R&D Div., Kyowa Hakko Kirin Co., Ltd. |
| Mar. 2021 | Executive Officer Director, Internal Audit Department, Kyowa Kirin Co., Ltd. (to present) |